Intellia Therapeutics Overview
Intellia Therapeutics Target Price
Where could NTLA trade next? Consensus target price: $23.
Get informed when a big investor buys or sells
+ FollowShare Price
$12.09
Average Target Price
$23.40
93.5% upside
93.5% upside10 analysts in the last 4 months
High: $49 | Low: $9
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-07 | Evercore ISI | $24 | 98.5% upside |  |
| 2026-07-15 | Wolfe ResearchAndy Chen | $9 |  25.6% downside | |
| 2026-07-10 | Wedbush | $17 | 40.6% upside | |
| 2026-06-15 | New Street | $25 | 106.8% upside | |
| 2026-05-13 | Bernstein | $17 | 40.6% upside | |
| 2026-05-12 | Canaccord Genuity | $49 | 305.3% upside | |
| 2026-04-27 | Chardan Capital | $30 | 148.1% upside | |
| 2026-04-27 | Leerink Partners | $35 | 189.5% upside | |
| 2026-04-27 | Morgan Stanley | $15 | 24.1% upside | |
| 2026-04-27 | Robert W. BairdJack Allen | $13 | 7.5% upside | |
| 2026-01-28 | KeyBanc | $25 | 106.8% upside | |
| 2026-01-27 | Robert W. BairdJack Allen | $7 | 42.1% downside | |
| 2025-11-11 | Evercore ISI | $8 | 33.8% downside | |
| 2025-11-10 | Truist Financial | $14 | 15.8% upside | |
| 2025-11-07 | Oppenheimer | $27 | 123.3% upside | |
| 2025-10-30 | WedbushDavid Nierengarten | $9 | 25.6% downside | |
| 2025-10-30 | H.C. WainwrightMitchell Kapoor | $18 | 48.9% upside | |
| 2025-10-30 | Robert W. BairdJack Allen | $9 | 25.6% downside | |
| 2025-10-28 | JMP Securities | $29 | 139.9% upside | |
| 2025-10-28 | Bernstein | $14.5 | 19.9% upside | |
| 2025-10-28 | BarclaysGena Wang | $24 | 98.5% upside | |
| 2025-10-28 | Tudor PickeringWilliam Pickering | $14.5 | 19.9% upside | |
| 2025-10-28 | RBC CapitalLuca Issi | $14 | 15.8% upside | |
| 2025-10-27 | Chardan Capital | $48 | 297% upside | |
| 2025-10-27 | H.C. WainwrightMitchell Kapoor | $25 | 106.8% upside | |
| 2025-10-06 | JMP SecuritiesSilvan Tuerkcan | $33 | 173% upside | |
| 2025-08-13 | GuggenheimDebjit Chattopadhyay | $14 | 15.8% upside | |
| 2025-02-28 | Goldman Sachs | $9 | 25.6% downside | |
| 2025-02-28 | Barclays | $26 | 115.1% upside | |
| 2024-11-11 | OppenheimerJay Olson | $60 | 396.3% upside | |
| 2024-10-24 | Robert W. BairdJack Allen | $18 | 48.9% upside | |
| 2024-08-09 | RBC CapitalLuca Issi | $54 | 346.7% upside | |
| 2024-06-24 | Stifel NicolausDae Gon Ha | $80 | 561.7% upside | |
| 2024-06-24 | Robert W. BairdJack Allen | $24 | 98.5% upside | |
| 2024-05-10 | BMO CapitalKostas Biliouris | $70 | 479% upside | |
| 2023-02-01 | Cantor Fitzgerald | $67 | 454.2% upside | |
| 2023-01-04 | Wells Fargo | $120 | 892.6% upside | |
| 2022-12-06 | Credit Suisse | $88 | 627.9% upside | |
| 2022-12-02 | Leerink Partners | $86 | 611.3% upside | |
| 2022-11-15 | Chardan Capital | $129 | 967% upside | |
| 2022-08-05 | Leerink Partners | $152 | 1157.2% upside | |
| 2022-08-05 | Chardan Capital | $146 | 1107.6% upside | |
| 2022-06-16 | BMO CapitalKostas Biliouris | $54 | 346.7% upside | |
| 2022-05-09 | JMP Securities | $110 | 809.8% upside | |
| 2022-05-09 | Raymond JamesSteven Seedhouse | $105 | 768.5% upside | |
| 2022-05-06 | Credit Suisse | $98 | 710.6% upside | |
| 2022-02-24 | RBC CapitalLuca Issi | $150 | 1140.7% upside | |
| 2022-02-18 | William BlairRaju Prasad | $144 | 1091.1% upside | |
| 2022-02-15 | Truist FinancialJoon Lee | $160 | 1223.4% upside | |
| 2022-02-03 | Piper SandlerSwapnil Malekar | $171 | 1314.4% upside | |